Psychiatry and Neurology, Neurology · Brooklyn, NY
NPI
1679730477
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
7
Medicare group memberships
Hospitals
4
Hospital affiliations
221 Parkville Ave, Ste 1
Brooklyn, NY, 11230
Phone (718) 975-4575
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
797 services
Medicare patients, 2024
252
Average age 73
Drug cost, 2024
$1.1M
2,882 prescriptions
Company payments, 2025
$1,407
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Irina Kogan was code 99213 (office e&m - established), 384 times for 181 patients. In total Irina Kogan billed 797 services in 19 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 384 | 181 | $67.08 | $26K |
| 95886 Electrical Nerve Conductivity | Office | 110 | 52 | $87.12 | $9,583 |
| 99203 Office E&M - New | Office | 82 | 82 | $98.78 | $8,100 |
| 95911 Electrical Nerve Conductivity | Office | 53 | 50 | $190.17 | $10K |
| 95816 Neurologic | Office | 41 | 41 | $361.18 | $15K |
| 99214 Office E&M - Established | Office | 37 | 32 | $115.40 | $4,270 |
| 76881 Ultrasound - Nonspecific | Office | 23 | 13 | $40.88 | $940 |
| 99204 Office E&M - New | Office | 18 | 18 | $152.23 | $2,740 |
By year: 2022 $119K for 1,011 services; 2023 $138K for 1,283 services; 2024 $80K for 797 services.
Medicare prescription drug claims, 2024
In 2024, the drug Irina Kogan prescribed most often to Medicare patients was Diclofenac Sodium, with 245 prescriptions and refills. In total Irina Kogan wrote 2,882 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 245 | 275 | 85 | $144K |
| Gabapentin Generic | 243 | 286 | 117 | $1,548 |
| Memantine Hcl Generic | 219 | 258 | 87 | $2,096 |
| Donepezil Hcl Generic | 161 | 211 | 64 | $1,361 |
| Ztlido Lidocaine | 117 | 141 | 42 | $52K |
| Nurtec Odt Rimegepant Sulfate | 115 | 117 | 53 | $166K |
| Doxepin Hcl Generic | 94 | 94 | 19 | $11K |
| Levetiracetam Generic | 82 | 92 | 23 | $1,094 |
| Meclizine Hcl Generic | 76 | 82 | 43 | $255 |
| Diclofenac Potassium Generic | 71 | 73 | 24 | $82K |
| Dihydroergotamine Mesylate Generic | 64 | 64 | 12 | $121K |
| Lidocaine Generic | 63 | 79 | 24 | $6,370 |
| Amitriptyline Hcl Generic | 52 | 54 | 30 | $209 |
| Quetiapine Fumarate Generic | 51 | 55 | 21 | $486 |
| Diclofenac Sodium Er Diclofenac Sodium | 47 | 47 | Under 11 | $3,821 |
Brand drugs: 743 claims; generic drugs: 2,139 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Irina Kogan $1,407 ($1,407 in general payments such as food, travel and fees) from 12 companies. The largest payer was Pfizer Inc. with $310.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 17 | $310 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $259 |
| Neurocrine BioSciences, Inc. NBIX | 9 | $244 |
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $140 |
| Abbvie Inc. ABBV | 4 | $94.71 |
| Braeburn Inc. | 2 | $80.26 |
| Alkermes, Inc. ALKS | 3 | $73.72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $61.21 |
| Axsome Therapeutics, Inc. AXSM | 2 | $50.6 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $46.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.